Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide

被引:25
|
作者
Kitasato, Lisa [1 ]
Tojo, Taiki [1 ,2 ]
Hatakeyama, Yuko [2 ]
Kameda, Ryo [1 ]
Hashikata, Takehiro [1 ]
Yamaoko-Tojo, Minako [1 ,3 ,4 ]
机构
[1] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan
[2] Kitasato Univ, Sch Med, Dept Cardioangiol, Sagamihara, Kanagawa 228, Japan
[3] Kitasato Univ, Special Dept Cardiac Rehabil & Prevent Cardiovasc, Sch Med, Sagamihara, Kanagawa 228, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Minami Ku, Sagamihara, Kanagawa 2520373, Japan
关键词
Atherosclerosis; Endothelial function; Cardiovascular disease prevention; OXIDATIVE STRESS GENERATION; IMPAIRED GLUCOSE-TOLERANCE; CROSS-SECTIONAL RELATIONS; CORONARY-HEART-DISEASE; SENSITIVE K+ CHANNEL; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; NITRIC-OXIDE; RISK-FACTORS; INSULIN-SECRETION;
D O I
10.1186/1475-2840-11-79
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The risk of cardiovascular complication in a diabetes patient is similar to that in a nondiabetic patient with a history of myocardial infarction. Although intensive control of glycemia achieved by conventional antidiabetic agents decreases microvascular complications such as retinopathy and nephropathy, no marked effect has been reported on macrovascular complications or all-cause mortality. Evidence from VADT, ACCORD, and ADVANCE would suggest that glycemic control has little effect on macrovascular outcomes. Moreover, in the case of ACCORD, intensive glycemic control may be associated with an increased risk of mortality. There is sufficient evidence that suggests that postprandial hyperglycemia may be an independent risk factor for cardiovascular disease in diabetes patients. However, there are no prospective clinical trials supporting the recommendation that lowering postprandial blood glucose leads to lower risk of cardiovascular outcomes. Mitiglinide is a short-acting insulinotropic agent used in type 2 diabetes treatment. It has a rapid stimulatory effect on insulin secretion and reduces postprandial plasma glucose level in patients with type 2 diabetes. Because of its short action time, it is unlikely to exert adverse effects related to hypoglycemia early in the morning and between meals. Mitiglinide reduces excess oxidative stress and inflammation, plays a cardioprotective role, and improves postprandial metabolic disorders. Moreover, mitiglinide add-on therapy with pioglitazone favorably affects the vascular endothelial function in type 2 diabetes patients. These data suggest that mitiglinide plays a potentially beneficial role in the improvement of postprandial hyperglycemia in type 2 diabetes patients and can be used to prevent cardiovascular diseases. Although the results of long-term, randomized, placebo-controlled trials for determining the cardiovascular effects of mitiglinide on clinical outcomes are awaited, this review is aimed at summarizing substantial insights into this topic.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus
    Santilli, F.
    Formoso, G.
    Sbraccia, P.
    Averna, M.
    Miccoli, R.
    Di Fulvio, P.
    Ganci, A.
    Pulizzi, N.
    Lattanzio, S.
    Ciabattoni, G.
    Consoli, A.
    Lauro, R.
    Patrono, C.
    Davi, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (04) : 828 - 837
  • [32] Effect of percutaneous electrical muscle stimulation on postprandial hyperglycemia in type 2 diabetes
    Miyamoto, Toshiaki
    Fukuda, Kazuhito
    Kimura, Tetsuya
    Matsubara, Yasushi
    Tsuda, Kinsuke
    Moritani, Toshio
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 96 (03) : 306 - 312
  • [33] The effect of nateglinide on postprandial hyperglycemia and oxidative stress in Type 2 diabetes mellitus
    Yoo, Jeong Seon
    Nam, Ji Sun
    Jung, Han Young
    Han, Jung Woo
    Cho, Min Ho
    Park, Jong Suk
    Ahn, Chul Woo
    Cha, Bong Soo
    Kim, Kyung Rae
    Lee, Hyun Chul
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S73 - S73
  • [34] Postprandial hyperglycemia is highly prevalent throughout the day in type 2 diabetes patients
    van Dijk, Jan-Willem
    Manders, Ralph J. F.
    Hartgens, Fred
    Stehouwer, Coen D.
    Praet, Stephan F. E.
    van Loon, Luc J. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (01) : 31 - 37
  • [35] Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus
    Esposito, K
    Giugliano, D
    Nappo, F
    Marfella, R
    CIRCULATION, 2004, 110 (02) : 214 - 219
  • [36] Influence of hyperglycemia on mitochondrial function in type 2 diabetes
    Rabol, Rasmus
    Hojberg, Patricia
    Haugaard, Steen B.
    Almdal, Thomas
    Madsbad, Sten
    Dela, Flemming
    DIABETES, 2007, 56 : A63 - A63
  • [37] Erratum to: Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus
    Jin Ah Jung
    Kohei Kaku
    Jae Hyeon Kim
    Jung-Ryul Kim
    Jae-Wook Ko
    Soo-Youn Lee
    Wooseong Huh
    Advances in Therapy, 2014, 31 : 149 - 149
  • [38] The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy
    Tanaka, Kenichi
    Okada, Yosuke
    Mori, Hiroko
    Torimoto, Keiichi
    Arao, Tadashi
    Tanaka, Yoshiya
    INTERNAL MEDICINE, 2018, 57 (01) : 65 - 70
  • [39] The effect of sex on endothelial function responses to clamped hyperglycemia in type 1 diabetes
    Ronnie Har
    Vesta Lai
    David Cherney
    Hypertension Research, 2014, 37 : 220 - 224
  • [40] The effect of sex on endothelial function responses to clamped hyperglycemia in type 1 diabetes
    Har, Ronnie
    Lai, Vesta
    Cherney, David
    HYPERTENSION RESEARCH, 2014, 37 (03) : 220 - 224